The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.

View software available in the Integrated Systems Biology and AI — Tailored Pharmacology and Precision Medicine Lab led by Hu ...